Millennium Management
MRNA icon

Millennium Management’s Moderna MRNA Stock Holding History

Millennium Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.41M Sell
47,500
-76,100
-62% -$3.55M ﹤0.01% 3690
2025
Q4 		$3.64M Sell
123,600
-452,500
-79% -$12.3M ﹤0.01% 3357
2025
Q3 		$14.9M Buy
576,100
+162,100
+39% +$4.52M 0.01% 1987
2025
Q2 		$11.4M Buy
414,000
+238,800
+136% +$6.29M 0.01% 2124
2025
Q1 		$4.97M Buy
175,200
+29,700
+20% +$1.05M ﹤0.01% 2870
2024
Q4 		$6.05M Buy
145,500
+8,600
+6% +$411K ﹤0.01% 2655
2024
Q3 		$9.15M Sell
136,900
-269,500
-66% -$24.7M ﹤0.01% 2255
2024
Q2 		$48.3M Buy
406,400
+183,900
+83% +$23.3M 0.02% 818
2024
Q1 		$23.7M Sell
222,500
-5,800
-3% -$585K 0.01% 1426
2023
Q4 		$22.7M Sell
228,300
-34,000
-13% -$2.86M 0.01% 1443
2023
Q3 		$27.1M Buy
262,300
+112,400
+75% +$12.5M 0.01% 1177
2023
Q2 		$18.2M Sell
149,900
-35,300
-19% -$4.71M 0.01% 1471
2023
Q1 		$28.4M Buy
185,200
+48,000
+35% +$7.92M 0.02% 1076
2022
Q4 		$24.6M Sell
137,200
-18,800
-12% -$3.07M 0.01% 1264
2022
Q3 		$18.4M Buy
156,000
+15,400
+11% +$2.34M 0.01% 1429
2022
Q2 		$20.1M Sell
140,600
-31,600
-18% -$4.52M 0.01% 1305
2022
Q1 		$29.7M Buy
172,200
+26,900
+19% +$4.53M 0.02% 1025
2021
Q4 		$36.9M Buy
145,300
+35,300
+32% +$10.3M 0.02% 930
2021
Q3 		$42.3M Sell
110,000
-90,000
-45% -$33.2M 0.03% 736
2021
Q2 		$47M Buy
200,000
+100,000
+100% +$17.9M 0.03% 639
2021
Q1 		$13.1M Buy
100,000
+71,000
+245% +$10.3M 0.01% 1504
2020
Q4 		$3.03M Buy
29,000
+19,000
+190% +$1.92M ﹤0.01% 2889
2020
Q3 		$708 Buy
+10,000
New +$697K ﹤0.01% 3370

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management's MRNA Position: Q1 2026 in Review

Millennium Management increased its Moderna (MRNA) stake by 153% in Q1 2026, buying an estimated $28.7M and bringing the position to 1,019,208 shares worth $51.8M. The position accounts for 0.02% of the portfolio, ranked #806.

Millennium Management first reported a position in MRNA in Q4 2018 and has held it in 28 quarters since. The position peaked at $98.4M in Q2 2021. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Millennium Management held 1,019,208 shares of Moderna worth $51.8M as of Q1 2026.
  • Millennium Management bought 615,573 Moderna shares in Q1 2026, an estimated $28.7M.
  • Moderna made up 0.02% of Millennium Management's portfolio in Q1 2026, its #806 holding.
  • Millennium Management first reported a position in Moderna in Q4 2018 and has held it in 28 quarters since.
  • Millennium Management's Moderna position peaked at $98.4M in Q2 2021.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.